Sponsor or institution

Clinical trials and research at Gadjah Mada University

As of November 12, 2026, Find a Trial lists 3 clinical trials run by Gadjah Mada University that are recruiting, in Indonesia. By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Comparing three transthoracic needle biopsy techniques for people with suspected lung cancer — Yogyakarta, Special Region of Yogyakarta Recruiting Dec 1, 2025
Ciprofloxacin versus ceftazidime for high-risk neutropenic fever in children with blood cancers Phase 4 Sleman, DI Yogyakarta Recruiting Jun 11, 2025
Home-based cardiac rehabilitation with family empowerment for people after acute coronary syndrome — Sleman, Special Region of Yogyakarta and 1 other locations Recruiting Oct 3, 2024

All recruiting trials (3)

Quick answers

How many clinical trials run by Gadjah Mada University are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in Indonesia. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.